(Yicai) Aug. 11 -- A unit of China’s Sino Biopharmaceutical has received market approval in Algeria for a biosimilar of ...

Palleon Pharmaceuticals has dosed the first subject in the randomised Phase II trial of E-602 (HLX79), a first-in-class human ...

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its ...

BIIB posts Q2 earnings and sales beat, lifts 2025 outlook on new drug growth and displays resilient MS performance.

The 2024 approvals included significant milestones in the biosimilar sector, with the FDA granting approval for the first biosimilar of Stelara, Wezlana and the first denosumab biosimilars, Wyost ...

Lupin and Zentiva, a pan-European pharmaceutical company, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar Certolizumab Pegol, across multiple markets ...

Hyderabad-based Dr. Reddy's Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

Biosimilars promise cost savings and improved patient access in Latin America, yet face significant regulatory and educational barriers hindering their uptake.

This biosimilars market report focuses on rising market complexity and recent activity, including two new approvals and four launches in Q2. Samsung Bioepis released its Third Quarter 2025 United ...